Seeking Alpha

BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs....

BioCryst Pharmaceuticals (BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%) vs. $23.6M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)